Ryan Zimmerman
Stock Analyst at BTIG
(4.16)
# 492
Out of 5,130 analysts
228
Total ratings
56.7%
Success rate
11.73%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Reiterates: Buy | $112 | $92.85 | +20.62% | 10 | Jan 8, 2026 | |
| ISRG Intuitive Surgical | Maintains: Buy | $589 → $616 | $586.24 | +5.08% | 22 | Jan 7, 2026 | |
| ENOV Enovis | Initiates: Buy | $41 | $29.68 | +38.14% | 1 | Jan 6, 2026 | |
| GKOS Glaukos | Reiterates: Buy | $116 | $112.92 | +2.73% | 15 | Jan 2, 2026 | |
| ORGO Organogenesis Holdings | Reiterates: Buy | $9 | $4.21 | +113.78% | 10 | Dec 26, 2025 | |
| CARL Carlsmed | Reiterates: Buy | $24 | $12.71 | +88.83% | 2 | Dec 15, 2025 | |
| RBOT Vicarious Surgical | Suspends: Neutral | n/a | $2.61 | - | 4 | Dec 12, 2025 | |
| SOLV Solventum | Upgrades: Buy | $100 | $86.14 | +16.09% | 2 | Dec 2, 2025 | |
| ALC Alcon | Reiterates: Buy | $91 | $80.13 | +13.57% | 13 | Nov 24, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $6 | $1.17 | +412.82% | 6 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $87 | $87.28 | -0.32% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $3.40 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $410 | $367.54 | +11.55% | 18 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $3 | $1.54 | +94.81% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1.5 | $0.68 | +119.94% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.90 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $30.24 | -7.41% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $18.31 | +25.61% | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $320 | $322.44 | -0.76% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $74.87 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $179.43 | +8.68% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $38.56 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $32.83 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $14.39 | +59.83% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $125.92 | +17.53% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.84 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $94.47 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $13.58 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $22.12 | +139.60% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.78 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $138.92 | +43.97% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $289.04 | +21.09% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $97.53 | +31.24% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.57 | +29.65% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $18.70 | +124.60% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.63 | +832.50% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $33.51 | - | 3 | Apr 2, 2020 |
Zimmer Biomet Holdings
Jan 8, 2026
Reiterates: Buy
Price Target: $112
Current: $92.85
Upside: +20.62%
Intuitive Surgical
Jan 7, 2026
Maintains: Buy
Price Target: $589 → $616
Current: $586.24
Upside: +5.08%
Enovis
Jan 6, 2026
Initiates: Buy
Price Target: $41
Current: $29.68
Upside: +38.14%
Glaukos
Jan 2, 2026
Reiterates: Buy
Price Target: $116
Current: $112.92
Upside: +2.73%
Organogenesis Holdings
Dec 26, 2025
Reiterates: Buy
Price Target: $9
Current: $4.21
Upside: +113.78%
Carlsmed
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $12.71
Upside: +88.83%
Vicarious Surgical
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.61
Upside: -
Solventum
Dec 2, 2025
Upgrades: Buy
Price Target: $100
Current: $86.14
Upside: +16.09%
Alcon
Nov 24, 2025
Reiterates: Buy
Price Target: $91
Current: $80.13
Upside: +13.57%
Humacyte
Nov 21, 2025
Reiterates: Buy
Price Target: $6
Current: $1.17
Upside: +412.82%
Nov 21, 2025
Reiterates: Buy
Price Target: $87
Current: $87.28
Upside: -0.32%
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.40
Upside: -
Nov 14, 2025
Reiterates: Buy
Price Target: $410
Current: $367.54
Upside: +11.55%
Nov 12, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.54
Upside: +94.81%
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.68
Upside: +119.94%
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.90
Upside: -
Nov 4, 2025
Upgrades: Buy
Price Target: $28
Current: $30.24
Upside: -7.41%
Oct 29, 2025
Reiterates: Buy
Price Target: $23
Current: $18.31
Upside: +25.61%
Oct 27, 2025
Reiterates: Buy
Price Target: $320
Current: $322.44
Upside: -0.76%
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $74.87
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $179.43
Upside: +8.68%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $38.56
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $32.83
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $14.39
Upside: +59.83%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $125.92
Upside: +17.53%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.84
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $94.47
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $13.58
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $22.12
Upside: +139.60%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.78
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $138.92
Upside: +43.97%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $289.04
Upside: +21.09%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $97.53
Upside: +31.24%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $11.57
Upside: +29.65%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $18.70
Upside: +124.60%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.63
Upside: +832.50%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $33.51
Upside: -